To attend virtually, please click the following link Zoom: https://baystatehealth.zoom.us/j/98118181227?pwd=thibm5qLg6Ypbwr967VvqvIAoRVoAn.1&from=addon
Objectives
After participating in this educational activity, attendees should be able to:
- Describe the historical trajectory of concepts of remodeling.
- Analyze clinical trial results related to remodeling and associated outcomes.
- Apply current concepts derived from remodeling data to the design of future clinical trials.
Presenter(s):
James Udelson, MD
Chief Physician Exec, CardioVascular Center
Professor of Medicine and Radiology
Tufts Medical Center
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
---|---|---|---|
James Udelson, MD | Speaker | Trial Cte for Merck, Alleviant, Reprieve, Cardurion, Fire1 | No |
The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.
James Udelson, MD is on the Trial Cte for Merck, Alleviant, Reprieve, Cardurion, Fire1 . These relationships has been reviewed, and any potential conflicts of interest have been mitigated.
None of the other planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)